KALLI MOLZAHN: Open Payments
NPI 1982366068 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,262 in 56 payments from 20 companies in 2025. Trend: 2023 $1,042 · 2024 $1,281 · 2025 $1,262
Food & beverage: $1,262
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $175 |
| Regeneron Healthcare Solutions, Inc. | 8 | $164 |
| Merck Sharp & Dohme LLC | 5 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $125 |
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| ABIOMED | 3 | $86 |
| Boston Scientific Corporation | 4 | $83 |
| Kestra Medical Technology Services, Inc. | 2 | $55 |
| CVRx, Inc. | 4 | $54 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
Products named: ELIQUIS, EVKEEZA, JARDIANCE, VERQUVO, LEQVIO, Assure WCD, Barostim Neo System, LUX-Dx Insertable Cardiac Monitor.
Industry payments across NV — which companies pay providers there.
